Clinical Trials Directory

Trials / Completed

CompletedNCT00842543

Fruit and Vegetable Juice Concentrate Effects on RBP4 and Antioxidant Capacity in Lean and Overweight 6-10 Year Old Boys

Effects Of A Fruit And Vegetable Juice Concentrate (FVJC) In-Vivo On Retinol Binding Protein 4 And Antioxidant Capacity In Normal And Overweight Boys -A Pilot Randomized Placebo Controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Nemours Children's Clinic · Academic / Other
Sex
Male
Age
6 Years – 10 Years
Healthy volunteers
Accepted

Summary

Our study aims to evaluate if the consumption of a Fruit and Vegetable Juice Concentrate (FVJC) vs. placebo can exert changes in the serum levels of Retinol Binding Protein 4 (RBP4), carotenoids, tocopherol, antioxidant capacity, pro-inflammatory markers, insulin sensitivity in conjunction with weight management in a cohort of lean as compared to overweight healthy six to ten year-old boys. The boys will undergo a detailed medical and family history and a complete physical examination during the screening visit. Careful anthropometric measures and body composition by DEXA will be performed. Nutritional and exercise counseling will be given at the start of the study. The outcome measures will include differences in serum RBP4, antioxidant levels, inflammatory markers and insulin sensitivity at baseline and six months after consumption of FVJC in a randomized double blind placebo control manner.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFruit and Vegetable Juice Concentrate (FVJC)Take FVJC or placebo twice a day for 6 months while receiving dietary and physical activity counseling from a Registered Dietician.
DIETARY_SUPPLEMENTPlaceboTake FVJC or placebo twice a day for 6 months while receiving dietary and physical activity counseling from a Registered Dietician.

Timeline

Start date
2008-07-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2009-02-12
Last updated
2013-09-26
Results posted
2013-09-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00842543. Inclusion in this directory is not an endorsement.